Product
Supplier
Encyclopedia
Inquiry
Home > News > Pharma News
ECHEMI chemical news

Pharma News

The global veterinary drug market will reach 537.2 billion in 2022

The global veterinary drug market will reach 537.2 billion in 2022

2021-01-25

In 2022, the global veterinary drug market will reach 537.2 billion yuan, and the market share of the top five manufacturers will exceed 60%. With the development of animal husbandry, the importance of veterinary drugs has gradually received attention fro

The third domestic company, Qilu Eltrodopal ethanolamine generic drug production

The third domestic company, Qilu Eltrodopal ethanolamine generic drug production

2021-01-22

On January 20th, according to the CDE official website, Qilu Pharmaceutical’s application for the 4 generic drug Eltropopa ethanolamine tablets was accepted by CDE, which means that Qilu Pharmaceutical has become the third domestic company to submit after

The price of veterinary raw materials has jumped, what is the reason?

The price of veterinary raw materials has jumped, what is the reason?

2021-01-22

On the one hand, there is a decrease in supply and poor logistics. On the other hand, there is an increase in demand, even more than in previous years. Supply and demand are imbalanced and contradictions are prominent.

Under the epidemic, 7 major trends in the global biomedical industry in 2021

Under the epidemic, 7 major trends in the global biomedical industry in 2021

2021-01-20

According to CB Insights analysis data, the global synthetic biology market in 2019 reached 5.3 billion US dollars. It is estimated that by 2024, compared with 2019, the compound annual growth rate (CAGR) of the synthetic biology market will increase by 2

Optimization of export structure of cephalosporin APIs from January to July 2020

Optimization of export structure of cephalosporin APIs from January to July 2020

2021-01-19

As a major producer and exporter of cephalosporin APIs, my country's export scale of related products has continued to grow in recent years. From 2015 to 2019, the export value increased from 436 million US dollars to 587 million US dollars

These varieties in the cardiovascular drug market will become the main force

These varieties in the cardiovascular drug market will become the main force

2021-01-18

Cardiovascular disease (CVD) is a disease caused by heart and vascular diseases, including coronary heart disease (heart disease), cerebrovascular disease (stroke), elevated blood pressure (hypertension)

Pharmaceutical intermediates: the future development of adenine

Pharmaceutical intermediates: the future development of adenine

2021-01-13

Adenine, also known as 6-aminopurine, has a chemical formula of C5H5N5. It is a fused ring system composed of pyrimidine and imidazole rings. Adenine in organisms is mainly synthesized from amino acids and small molecules as starting materials through

Upstream changes, the export price of paracetamol APIs will skyrocket?

Upstream changes, the export price of paracetamol APIs will skyrocket?

2021-01-11

Recently, the news that Anhui Bayi Chemical Co., Ltd., the country's largest producer of para-aminophenol, was seized and was about to suspend production has caused a strong shock in the paracetamol industry

Exclusive original! Anisodamine hydrobromide tablets

Exclusive original! Anisodamine hydrobromide tablets

2021-01-07

A few days ago, industry news showed that the exclusive drug anisodamine hydrobromide tablets developed by Chengdu First Pharmaceutical Co., Ltd. (abbreviated as Chengyi Pharmaceutical) will be approved for marketing in 2021, focusing on the target market

FDA issues new guidelines, accelerating the development of personalized medicine

FDA issues new guidelines, accelerating the development of personalized medicine

2021-01-07

On January 4, 2021, the U.S. FDA issued a recommended procedure for the new drug application (IND) of individualized antisense oligonucleotide (ASO) products. The guidance provides clear information about the early development and IND submission process

The most noteworthy new 'blockbuster' drugs in 2020

The most noteworthy new 'blockbuster' drugs in 2020

2021-01-05

The so-called blockbuster is a product with annual sales exceeding 1 billion U.S. dollars within 5 years after being put on the market. Among the new drugs approved for the first time in 2020, 10-13 products are expected to reach this level.

Forecast: 9 major events in the field of biomedicine in 2021!

Forecast: 9 major events in the field of biomedicine in 2021!

2021-01-05

In 2020, mankind has made a series of exciting progress in the field of biomedicine. For example, the new crown vaccine/therapy has been developed at a record speed, and the new generation of AlphaFold artificial intelligence system has made a blockbuster

Vitamin market staged the end of the year

Vitamin market staged the end of the year

2020-12-29

Recent safety accidents, environmental protection, power curtailment and other factors have affected the resonance, and the vitamin market rebounded. In the northern region, Shandong, Shanxi, Hebei, Henan and other places issued successive environmental

The FDA approved 53 innovative drugs this year: what trends do they represent?

The FDA approved 53 innovative drugs this year: what trends do they represent?

2020-12-28

2020 is coming to an end. As of press time, the Center for Drug Evaluation and Research (CDER) of the US FDA has approved 53 innovative drugs.

November PPI of chemical raw material medicine manufacturing industry

November PPI of chemical raw material medicine manufacturing industry

2020-12-25

According to the China Reporting Hall's monitoring of the producer price index (PPI) of the chemical pharmaceutical raw material manufacturing industry from January to November 2020

Top 10 blockbuster drugs with patents expiring in 2020

Top 10 blockbuster drugs with patents expiring in 2020

2020-12-24

For a long time, pharmaceutical companies have relied on the patent protection of medicines to obtain market monopoly. With the expiration of pharmaceutical patents, generic drugs have entered the market.

Study finds metformin reduced COVID-19 death risks in women

Study finds metformin reduced COVID-19 death risks in women

2020-12-23

University of Minnesota Medical School and UnitedHealth Group (NYSE: UNH) researchers found that metformin was associated with significantly reduced COVID-19 death risks in women in one of the world's largest observational studies of COVID-19 patients.

KU Leuven vaccine candidate protects against COVID-19 and yellow fever

KU Leuven vaccine candidate protects against COVID-19 and yellow fever

2020-12-23

Virologists at the Rega Institute at KU Leuven (Belgium) have developed a vaccine candidate against COVID-19 based on the yellow fever vaccine, which as a result also works against yellow fever.

AZD1222 Oxford Phase III trials interim analysis results published in The Lancet

AZD1222 Oxford Phase III trials interim analysis results published in The Lancet

2020-12-23

Results of an interim analysis of the Phase III programme conducted by Oxford University with AZD1222, peer-reviewed and published in The Lancet today, demonstrated that the vaccine is safe and effective at preventing symptomatic COVID-19 and that it prot

Pfizer and BioNTech achieve Health Canada authorization for their vaccine to com

Pfizer and BioNTech achieve Health Canada authorization for their vaccine to com

2020-12-23

Pfizer Canada and BioNTech will supply the Government of Canada a minimum of 20 million doses (and up to 76 million doses) of the vaccine through 2021.

  • Pharmaceutical Industry Overview

    The magazine has been officially published in August 2024 and will be distributed at CPHI Korea 2024 and CPHI Milan 2024. It could be permanently available for download online. We sincerely invite you to join us in the publicity, making full use of the influence of the journal to promote your brand & products, expand your corporate influence in the global market.
    Published in: Aug. 2024

ECHEMI Partner

Complaint
Email:
Message:
Send Message